These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11354308)

  • 41. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
    Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
    Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thioredoxin reductase inhibitors: a patent review.
    Zhang B; Zhang J; Peng S; Liu R; Li X; Hou Y; Han X; Fang J
    Expert Opin Ther Pat; 2017 May; 27(5):547-556. PubMed ID: 27977313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticancer and Antiangiogenic Iron(II) Complexes That Target Thioredoxin Reductase to Trigger Cancer Cell Apoptosis.
    Xie L; Luo Z; Zhao Z; Chen T
    J Med Chem; 2017 Jan; 60(1):202-214. PubMed ID: 28001402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural product based inhibitors of the thioredoxin-thioredoxin reductase system.
    Wipf P; Lynch SM; Birmingham A; Tamayo G; Jiménez A; Campos N; Powis G
    Org Biomol Chem; 2004 Jun; 2(11):1651-8. PubMed ID: 15162219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
    Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
    Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small molecule inhibitors of mammalian thioredoxin reductase.
    Cai W; Zhang L; Song Y; Wang B; Zhang B; Cui X; Hu G; Liu Y; Wu J; Fang J
    Free Radic Biol Med; 2012 Jan; 52(2):257-65. PubMed ID: 22064364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thioredoxin redox control of cell growth and death and the effects of inhibitors.
    Powis G; Kirkpatrick DL; Angulo M; Baker A
    Chem Biol Interact; 1998 Apr; 111-112():23-34. PubMed ID: 9679540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On the potential of thioredoxin reductase inhibitors for cancer therapy.
    Urig S; Becker K
    Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase.
    Tibodeau JD; Benson LM; Isham CR; Owen WG; Bible KC
    Antioxid Redox Signal; 2009 May; 11(5):1097-106. PubMed ID: 18999987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway.
    Lan L; Zhao F; Wang Y; Zeng H
    Eur J Pharmacol; 2007 Jan; 555(2-3):83-92. PubMed ID: 17116300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update.
    Zhang J; Zhang B; Li X; Han X; Liu R; Fang J
    Med Res Rev; 2019 Jan; 39(1):5-39. PubMed ID: 29727025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The thioredoxin/thioredoxin reductase redox system and control of cell growth.
    Powis G; Oblong JE; Gasdaska PY; Berggren M; Hill SR; Kirkpatrick DL
    Oncol Res; 1994; 6(10-11):539-44. PubMed ID: 7620223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and molecular recognition studies on small-molecule inhibitors for thioredoxin reductase.
    Zhang D; Xu Z; Yuan J; Zhao YX; Qiao ZY; Gao YJ; Yu GA; Li J; Wang H
    J Med Chem; 2014 Oct; 57(19):8132-9. PubMed ID: 25249032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How can we improve the design of small molecules to target thioredoxin reductase for treating cancer?
    Xu J; Fang J
    Expert Opin Drug Discov; 2021 Apr; 16(4):331-333. PubMed ID: 33307863
    [No Abstract]   [Full Text] [Related]  

  • 55. New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insights.
    Abyar F; Tabrizi L
    Biometals; 2020 Jun; 33(2-3):107-122. PubMed ID: 32246384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
    Ng HL; Ma X; Chew EH; Chui WK
    J Med Chem; 2017 Mar; 60(5):1734-1745. PubMed ID: 28177228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dithiaarsanes induce oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting thioredoxin reductase.
    Liu Y; Duan D; Yao J; Zhang B; Peng S; Ma H; Song Y; Fang J
    J Med Chem; 2014 Jun; 57(12):5203-11. PubMed ID: 24867309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors.
    Millet R; Urig S; Jacob J; Amtmann E; Moulinoux JP; Gromer S; Becker K; Davioud-Charvet E
    J Med Chem; 2005 Nov; 48(22):7024-39. PubMed ID: 16250662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents.
    Sun Y; Rigas B
    Cancer Res; 2008 Oct; 68(20):8269-77. PubMed ID: 18922898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Properties and biological activities of thioredoxins.
    Powis G; Montfort WR
    Annu Rev Pharmacol Toxicol; 2001; 41():261-95. PubMed ID: 11264458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.